(R)-(+)-1-(3-甲氧基苯基)乙胺 | 88196-70-7

• 物质功能分类: 有机原料 - 氨基化合物
• 分子结构分类: 有机化合物 - 苯类化合物 - 苯酚醚
• 中文名称: (R)-(+)-1-(3-甲氧基苯基)乙胺
• 中文别名: (R)-1-(3-甲氧基苯基)乙胺
• 英文名称: (R)-1-(3-methoxyphenyl)ethylamine
• 英文别名: (R)-1-(3-methoxyphenyl)ethanamine；(R)-1-(3-methoxyphenyl)ethan-1-amine；(R)-3-methoxy-α-methylbenzylamine；(1R)-1-(3-methoxyphenyl)ethan-1-amine；(1R)-1-(3-methoxyphenyl)ethanamine
• CAS: 88196-70-7
• 化学式: C₉H₁₃NO
• 分子量: 151.208
• InChiKey: CJWGCBRQAHCVHW-SSDOTTSWSA-N

物化性质

• 熔点：
  5℃
• 沸点：
  66°C 0,4mm
• 密度：
  1.023
• 闪点：
  66°C/0.38mm
• LogP：
  1.5 at 23℃ and pH10.5
• 稳定性/保质期：
  按规定使用和贮存的不会分解，避免与氧化物接触。

计算性质

• 辛醇/水分配系数(LogP)：
  1.6
• 重原子数：
  11
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.33
• 拓扑面积：
  35.2
• 氢给体数：
  1
• 氢受体数：
  2

安全信息

• 危险等级：
  8
• 安全说明：
  S26,S36/37/39,S45
• 危险类别码：
  R21/22,R34
• 海关编码：
  2922299090
• 包装等级：
  III
• 危险品运输编号：
  UN 2735
• 危险类别：
  8,6.1
• 危险性防范说明：
  P261,P273,P280,P305+P351+P338,P310
• 危险性描述：
  H314,H331,H412
• 储存条件：
  应存放在密闭、阴凉、干燥的地方。

SDS

---

SECTION 1: Identification of the substance/mixture and of the company/undertaking
Product identifiers
: (R)-3-Methoxy-α-methylbenzylamine
Product name
REACH No. : A registration number is not available for this substance as the substance
or its uses are exempted from registration, the annual tonnage does not
require a registration or the registration is envisaged for a later
registration deadline.
CAS-No. : 88196-70-7

---

SECTION 2: Hazards identification
Classification of the substance or mixture
Classification according to Regulation (EC) No 1272/2008
Acute toxicity, Inhalation (Category 3), H331
Skin corrosion (Category 1B), H314
For the full text of the H-Statements mentioned in this Section, see Section 16.
Classification according to EU Directives 67/548/EEC or 1999/45/EC
C Corrosive R34
Xn Harmful R20
For the full text of the R-phrases mentioned in this Section, see Section 16.
Label elements
Labelling according Regulation (EC) No 1272/2008
Pictogram
Signal word Danger
Hazard statement(s)
Causes severe skin burns and eye damage.
Toxic if inhaled.
Precautionary statement(s)
Avoid breathing dust/ fume/ gas/ mist/ vapours/ spray.
Wear protective gloves/ protective clothing/ eye protection/ face
protection.
P305 + P351 + P338 IF IN EYES: Rinse cautiously with water for several minutes. Remove
contact lenses, if present and easy to do. Continue rinsing.
Immediately call a POISON CENTER or doctor/ physician.
Supplemental Hazard none
Statements
According to European Directive 67/548/EEC as amended.
Hazard symbol(s) C Corrosive
R-phrase(s)
R20 Harmful by inhalation.
R34 Causes burns.
S-phrase(s)
S26 In case of contact with eyes, rinse immediately with plenty of water and
seek medical advice.
S36/37/39 Wear suitable protective clothing, gloves and eye/face protection.
S45 In case of accident or if you feel unwell, seek medical advice immediately
(show the label where possible).
Other hazards - none

---

SECTION 3: Composition/information on ingredients
Mixtures
Synonyms : (R)-1-(3-Methoxyphenyl)ethylamine
Formula : C9H13NO
Molecular Weight : 151,21 g/mol
Hazardous ingredients according to Regulation (EC) No 1272/2008
Component Classification Concentration
(R)-1-(3-Methoxyphenyl) ethylamine
CAS-No. 88196-70-7 Acute Tox. 3; Skin Corr. 1B; <= 100 %
H314, H331
(S)-(-)-3-Methoxy-α-methylbenzylamine
CAS-No. 82796-69-8 Acute Tox. 4; Acute Tox. 3; < 5 %
Skin Corr. 1B; Aquatic Chronic
3; H302, H314, H331, H412
Hazardous ingredients according to Directive 1999/45/EC
Component Classification Concentration
(R)-1-(3-Methoxyphenyl) ethylamine
CAS-No. 88196-70-7 C, R20 - R34 <= 100 %
(S)-(-)-3-Methoxy-α-methylbenzylamine
CAS-No. 82796-69-8 C, Xn, R20 - R22 - R34 <5%
For the full text of the H-Statements and R-Phrases mentioned in this Section, see Section 16

---

SECTION 4: First aid measures
Description of first aid measures
General advice
Consult a physician. Show this safety data sheet to the doctor in attendance.
If inhaled
If breathed in, move person into fresh air. If not breathing, give artificial respiration. Consult a physician.
In case of skin contact
Take off contaminated clothing and shoes immediately. Wash off with soap and plenty of water. Take
victim immediately to hospital. Consult a physician.
In case of eye contact
Rinse thoroughly with plenty of water for at least 15 minutes and consult a physician.
If swallowed
Do NOT induce vomiting. Never give anything by mouth to an unconscious person. Rinse mouth with
water. Consult a physician.
Most important symptoms and effects, both acute and delayed
The most important known symptoms and effects are described in the labelling (see section 2.2) and/or in
section 11
Indication of any immediate medical attention and special treatment needed
no data available

---

SECTION 5: Firefighting measures
Extinguishing media
Suitable extinguishing media
Use water spray, alcohol-resistant foam, dry chemical or carbon dioxide.
Special hazards arising from the substance or mixture
Carbon oxides, nitrogen oxides (NOx), Metal oxides
Advice for firefighters
Wear self contained breathing apparatus for fire fighting if necessary.
Further information
no data available

---

SECTION 6: Accidental release measures
Personal precautions, protective equipment and emergency procedures
Wear respiratory protection. Avoid breathing vapours, mist or gas. Ensure adequate ventilation.
Evacuate personnel to safe areas.
For personal protection see section 8.
Environmental precautions
Prevent further leakage or spillage if safe to do so. Do not let product enter drains. Discharge into the
environment must be avoided.
Methods and materials for containment and cleaning up
Soak up with inert absorbent material and dispose of as hazardous waste. Keep in suitable, closed
containers for disposal.
Reference to other sections
For disposal see section 13.

---

SECTION 7: Handling and storage
Precautions for safe handling
Avoid contact with skin and eyes. Avoid inhalation of vapour or mist.
Normal measures for preventive fire protection.
For precautions see section 2.2.
Conditions for safe storage, including any incompatibilities
Keep container tightly closed in a dry and well-ventilated place. Containers which are opened must be
carefully resealed and kept upright to prevent leakage. Store in cool place.
Specific end use(s)
A part from the uses mentioned in section 1.2 no other specific uses are stipulated

---

SECTION 8: Exposure controls/personal protection
Control parameters
Components with workplace control parameters
Exposure controls
Appropriate engineering controls
Avoid contact with skin, eyes and clothing. Wash hands before breaks and immediately after handling
the product.
Personal protective equipment
Eye/face protection
Tightly fitting safety goggles. Faceshield (8-inch minimum). Use equipment for eye protection
tested and approved under appropriate government standards such as NIOSH (US) or EN
166(EU).
Skin protection
Handle with gloves. Gloves must be inspected prior to use. Use proper glove removal technique
(without touching glove's outer surface) to avoid skin contact with this product. Dispose of
contaminated gloves after use in accordance with applicable laws and good laboratory practices.
Wash and dry hands.
The selected protective gloves have to satisfy the specifications of EU Directive 89/686/EEC and
the standard EN 374 derived from it.
Body Protection
Complete suit protecting against chemicals, The type of protective equipment must be selected
according to the concentration and amount of the dangerous substance at the specific workplace.
Respiratory protection
Where risk assessment shows air-purifying respirators are appropriate use a full-face respirator
with multi-purpose combination (US) or type ABEK (EN 14387) respirator cartridges as a backup
to engineering controls. If the respirator is the sole means of protection, use a full-face supplied air
respirator. Use respirators and components tested and approved under appropriate government
standards such as NIOSH (US) or CEN (EU).
Control of environmental exposure
Prevent further leakage or spillage if safe to do so. Do not let product enter drains. Discharge into
the environment must be avoided.

---

SECTION 9: Physical and chemical properties
Information on basic physical and chemical properties
a) Appearance Form: liquid
Colour: colourless, light yellow
b) Odour amine-like
c) Odour Threshold no data available
d) pH 10,9 at 10 g/l at 20 °C
e) Melting point/freezing 66 °C at 0,5 hPa
point
f) Initial boiling point and no data available
boiling range
g) Flash point no data available
h) Evapouration rate no data available
i) Flammability (solid, gas) no data available
j) Upper/lower no data available
flammability or
explosive limits
k) Vapour pressure no data available
l) Vapour density no data available
m) Relative density no data available
n) Water solubility 10 g/l at 20 °C
o) Partition coefficient: n- no data available
octanol/water
p) Auto-ignition no data available
temperature
q) Decomposition no data available
temperature
r) Viscosity no data available
s) Explosive properties no data available
t) Oxidizing properties no data available
Other safety information
no data available

---

SECTION 10: Stability and reactivity
Reactivity
no data available
Chemical stability
Stable under recommended storage conditions.
Possibility of hazardous reactions
no data available
Conditions to avoid
no data available
Incompatible materials
no data available
Hazardous decomposition products
Other decomposition products - no data available
In the event of fire: see section 5

---

SECTION 11: Toxicological information
Information on toxicological effects
Acute toxicity
no data available
Skin corrosion/irritation
no data available
Serious eye damage/eye irritation
no data available
Respiratory or skin sensitisation
no data available
Germ cell mutagenicity
no data available
Carcinogenicity
IARC: No component of this product present at levels greater than or equal to 0.1% is identified as
probable, possible or confirmed human carcinogen by IARC.
Reproductive toxicity
no data available
Specific target organ toxicity - single exposure
no data available
Specific target organ toxicity - repeated exposure
no data available
Aspiration hazard
no data available
Additional Information
RTECS: Not available
To the best of our knowledge, the chemical, physical, and toxicological properties have not been
thoroughly investigated.

---

SECTION 12: Ecological information
Toxicity
no data available
Persistence and degradability
no data available
Bioaccumulative potential
no data available
Mobility in soil
no data available
Results of PBT and vPvB assessment
PBT/vPvB assessment not available as chemical safety assessment not required/not conducted
Other adverse effects
Harmful to aquatic life.

---

SECTION 13: Disposal considerations
Waste treatment methods
Product
Offer surplus and non-recyclable solutions to a licensed disposal company. Contact a licensed
professional waste disposal service to dispose of this material.
Contaminated packaging
Dispose of as unused product.

---

SECTION 14: Transport information
UN number
ADR/RID: 2735 IMDG: 2735 IATA: 2735
UN proper shipping name
ADR/RID: AMINES, LIQUID, CORROSIVE, N.O.S. ((R)-1-(3-Methoxyphenyl) ethylamine)
IMDG: AMINES, LIQUID, CORROSIVE, N.O.S. ((R)-1-(3-Methoxyphenyl) ethylamine)
IATA: Amines, liquid, corrosive, n.o.s. ((R)-1-(3-Methoxyphenyl) ethylamine)
Transport hazard class(es)
ADR/RID: 8 IMDG: 8 IATA: 8
Packaging group
ADR/RID: II IMDG: II IATA: II
Environmental hazards
ADR/RID: no IMDG Marine pollutant: no IATA: no
Special precautions for user
no data available

---

SECTION 15: Regulatory information
This safety datasheet complies with the requirements of Regulation (EC) No. 1907/2006.
Safety, health and environmental regulations/legislation specific for the substance or mixture
no data available
Chemical Safety Assessment

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  (R)-(+)-1-(3-甲氧基苯基)乙胺 以 氢溴酸 为溶剂， 以to give (R)-1-(3-hydroxyphenyl)ethylamine的产率得到(R)-3-(1-氨基乙基)苯酚
  参考文献：
  名称：

  SALTY TASTE ENHANCER

  摘要：

  本发明提供了一种具有增强咸味活性的化合物，以及含有该化合物的增强咸味剂等。本发明涉及一种用于食品或饮料的增强咸味剂，其包含下式所示的化合物：其中每个符号如规范中所定义，或其可食用盐。

  公开号：

  US20140004243A1
• 作为产物：
  描述：

  N-(3-methoxy-benzylidene)-P,P-diphenylphosphonamide 在 盐酸 、 (1R,2S)-1-phenyl-2-(N-methyl-N-benzylamino)propan-1-ol 、 水 作用下， 以 甲醇 、 甲苯 为溶剂， 反应 48.0h， 生成 (R)-(+)-1-(3-甲氧基苯基)乙胺
  参考文献：
  名称：

  二甲基锌/二苯基膦基嘧啶不对称合成拟钙剂NPS R-568的方法

  摘要：

  描述了使用（1 R，2 S）-N-苄基麻黄碱促进的二甲基锌与衍生自3-甲氧基苯甲醛的二苯基膦基嘧啶的不对称合成拟钙剂NPS R-568 。通过衍生化和手性固定相HPLC分析确定关键胺片段的对映体比率为93：7（86％ee），有利于（R）-对映体。版权所有©2010 John Wiley＆Sons，Ltd.

  DOI：

  10.1002/aoc.1723

文献信息

• A process for the preparation of rivastigmine or a salt thereof
  申请人：Dr. Reddy's Laboratories Ltd.

  公开号：EP1980552A3

  公开（公告）日：2008-10-29

  There are provided processes for making rivastigmine. In one embodiment, the process includes reacting S-(-)-[1-(3-hydroxyphenyl)ethyl]dimethylamine with N-ethyl-N-methyl carbamoyl chloride in the presence of an organic base to obtain a free base of rivastigmine.

  提供了制备利伐司明的过程。在一个实施例中，该过程包括在有机碱的存在下，将S-(-)-[1-(3-羟基苯基)乙基]二甲基胺与N-乙基-N-甲基氨基甲酰氯反应，以获得利伐司明的自由碱。
• Asymmetric Synthesis of Nonracemic Primary Amines via Spiroborate-Catalyzed Reduction of Pure (<i>E</i>)- and (<i>Z</i>)-<i>O</i>-Benzyloximes: Applications toward the Synthesis of Calcimimetic Agents
  作者：Wenhua Ou、Sandraliz Espinosa、Héctor J. Meléndez、Silvia M. Farré、Jaime L. Alvarez、Valerie Torres、Ileanne Martínez、Kiara M. Santiago、Margarita Ortiz-Marciales

  DOI：10.1021/jo400371x

  日期：2013.6.7

  Highly enantiopure (1-aryl)- and (1-naphthyl)-1-ethylamines were synthesized by the borane-mediated reduction of single-isomeric (E)- and (Z)-O-benzyloxime ethers using the stable spiroborate ester derived from (S)-diphenyl valinol and ethylene glycol as the chiral catalyst. Primary (R)-arylethylamines were prepared by the reduction of pure (Z)-ethanone oxime ethers in up to 99% ee using 15% of catalyst

  使用衍生自稳定的螺硼酸酯，通过硼烷介导的单一异构体 ( E )- 和 ( Z ) -O-苄基肟醚的还原，合成了高对映体纯的 (1-芳基)-和 (1-萘基)-1-乙胺( S )-二苯基缬氨醇和乙二醇作为手性催化剂。伯 ( R )-芳基乙胺是通过使用 15% 的催化剂将纯 ( Z )-乙酮肟醚还原至 99% ee来制备的。描述了使用对映纯(1-萘-1-基)乙胺作为手性前体合成新的和已知的拟钙剂类似物的两种方便且容易的方法。
• PYRAZOLYL-CONTAINING TRICYCLIC DERIVATIVE, PREPARATION METHOD THEREFOR AND USE THEREOF
  申请人：Jiangsu Hansoh Pharmaceutical Group Co., Ltd.

  公开号：US20200247815A1

  公开（公告）日：2020-08-06

  The present invention relates to pyrazolyl-containing tricyclic derivative, a preparation method therefor and the use thereof. In particular, the present invention relates to a compound as shown in the general formula (I), a preparation method therefor and a pharmaceutical composition containing the compound, and the use thereof as a protease such as ERK (MAPK) inhibitor in the treatment of cancers, bone diseases, inflammatory diseases, immunological diseases, nervous system diseases, metabolic diseases, respiratory diseases and heart diseases, wherein the definition of each substituent in the general formula (1) is the same as defined in the description.

  本发明涉及吡唑基含有的三环衍生物，其制备方法及其用途。具体而言，本发明涉及一种如通式(I)所示的化合物，其制备方法及含有该化合物的药物组合物，以及将其用作蛋白酶，如ERK（MAPK）抑制剂，用于治疗癌症、骨疾病、炎症性疾病、免疫疾病、神经系统疾病、代谢性疾病、呼吸系统疾病和心脏疾病，其中通式（1）中每个取代基的定义与描述中定义的相同。
• Continuous‐Flow Amide and Ester Reductions Using Neat Borane Dimethylsulfide Complex
  作者：Sándor B. Ötvös、C. Oliver Kappe

  DOI：10.1002/cssc.201903459

  日期：2020.4.7

  importance in synthetic chemistry, and there are numerous protocols for executing these transformations employing traditional batch conditions. Notably, strategies based on flow chemistry, especially for amide reductions, are much less explored. Herein, a simple process was developed in which neat borane dimethylsulfide complex (BH3 ⋅DMS) was used to reduce various esters and amides under continuous-flow conditions

  酰胺和酯的还原在合成化学中至关重要，有许多使用传统间歇条件进行这些转化的方案。值得注意的是，很少研究基于流动化学的策略，尤其是酰胺还原的策略。本文中，开发了一种简单的方法，其中使用纯硼烷二甲基硫醚络合物（BH3·DMS）在连续流动条件下还原各种酯和酰胺。利用可商购的硼烷试剂的无溶剂性质，实现了高底物浓度，从而实现了出色的生产率和E因子的显着降低。另外，在精心优化的短停留时间的情况下，以高选择性和高收率获得了相应的醇和胺。药物相关产品的多克级合成进一步证实了廉价且易于实施的流程协议的合成效用。由于其有益的特征，包括低的溶剂和还原剂消耗，高的选择性，简单性和固有的可扩展性，与使用金属氢化物作为还原剂的大多数典型的批量还原相比，本发明的方法对环境的关注较少。
• [EN] 4-PYRAZOLYL-N-ARYLPYRIMIDIN-2-AMINES AND 4-PYRAZOLYL-N-HETEROARYLPYRIMIDIN-2-AMINES AS JANUS KINASE INHIBITORS<br/>[FR] 4-PYRAZOLYL-N-ARYLPYRIMIDIN-2-AMINES ET 4-PYRAZOLYL-N-HÉTÉROARYLPYRIMIDIN-2-AMINES EN TANT QU'INHIBITEURS DE JANUS KINASE
  申请人：INCYTE CORP

  公开号：WO2009064835A1

  公开（公告）日：2009-05-22

  The present invention provides substituted bicyclic heteroaryl compounds, 5 including, for example, 4-pyrazoIyI-N-arylpyrirnidin-2-arnines and 4-pyrazolyl-N-heteroarylpyτimidin-2-amines that modulate the activity of kinases and are useful in the treatment of diseases related to activity of kinases including, for example, immune-related diseases, skin disorders, myeloid proliferative disorders, cancer, and other diseases.formule :(1)

  本发明提供了取代的双环杂环芳基化合物，包括例如4-吡唑基-N-芳基吡啶-2-胺和4-吡唑基-N-杂环芳基嘧啶-2-胺，这些化合物调节激酶的活性，在治疗与激酶活性相关的疾病方面具有用处，例如免疫相关疾病、皮肤疾病、髓细胞增生性疾病、癌症和其他疾病。公式：(1)